Charles River Laboratories International (CRL) Leases (2019 - 2025)
Historic Leases for Charles River Laboratories International (CRL) over the last 9 years, with Q3 2025 value amounting to $374.3 million.
- Charles River Laboratories International's Leases fell 281.98% to $374.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.3 million, marking a year-over-year decrease of 281.98%. This contributed to the annual value of $412.5 million for FY2024, which is 468.52% up from last year.
- Charles River Laboratories International's Leases amounted to $374.3 million in Q3 2025, which was down 281.98% from $385.8 million recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Leases peaked at $412.5 million during Q4 2024, and registered a low of $197.7 million during Q1 2021.
- In the last 5 years, Charles River Laboratories International's Leases had a median value of $384.4 million in 2024 and averaged $358.4 million.
- Per our database at Business Quant, Charles River Laboratories International's Leases soared by 6909.59% in 2021 and then plummeted by 589.28% in 2024.
- Quarter analysis of 5 years shows Charles River Laboratories International's Leases stood at $292.9 million in 2021, then surged by 33.73% to $391.8 million in 2022, then rose by 0.58% to $394.0 million in 2023, then rose by 4.69% to $412.5 million in 2024, then dropped by 9.26% to $374.3 million in 2025.
- Its Leases stands at $374.3 million for Q3 2025, versus $385.8 million for Q2 2025 and $402.9 million for Q1 2025.